The complex of PP1 with the leucine-rich repeat protein SHOC2 promotes tumor growth in a subset of KRAS-mutant NSCLC cell lines by dephosphorylating a critical inhibitory site on RAF kinases, resulting in RAF-ERK pathway activation. The gene discussed is KRAS; the disease is neoplasm.